Qiancheng Hu

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Dan Cao · 2 shared papers, 2019–2022 · strength 0.32
   • Paper Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanc… DOI 10.1136/bmjopen-2021-050558↗
   • Paper Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients wi… DOI 10.1186/s13014-019-1330-0↗
2. Peng Cao · 2 shared papers, 2019 · strength 0.23
   • Paper Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network met… DOI 10.1097/md.0000000000015761↗
   • Paper Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients wi… DOI 10.1186/s13014-019-1330-0↗
3. Wanrui Lv · 1 shared paper, 2022 · strength 0.20
   • Paper Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanc… DOI 10.1136/bmjopen-2021-050558↗
4. Xin Wang · 1 shared paper, 2022 · strength 0.20
   • Paper Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanc… DOI 10.1136/bmjopen-2021-050558↗
5. Dan Cao · 1 shared paper, 2019 · strength 0.11
   • Paper Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network met… DOI 10.1097/md.0000000000015761↗
6. Ye Chen · 1 shared paper, 2019 · strength 0.11
   • Paper Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network met… DOI 10.1097/md.0000000000015761↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.